Generation of an urine-derived induced pluripotent stem cell line WMUi017-A from a X-linked Renpenning syndrome (X-RSY) patient with the hemizygous PQBP1 gene mutation p.P609A (c.1825C>G)

被引：3
|
作者：
Guo, Xiaoling [1 ,2 ,3 ]
Zhang, Xufei [1 ,2 ,3 ]
Wang, Linlin [1 ,2 ,3 ]
He, Lingyun [1 ,2 ,4 ]
Ding, Yinjuan [1 ,2 ,3 ]
Chen, Huihui [1 ,2 ,3 ]
Wang, Dexuan [1 ,2 ,3 ]
Rong, Xing [1 ,2 ,3 ]
Shen, Xian [1 ,2 ,4 ]
Lin, Jian [1 ,2 ,5 ]
Chu, Maoping [1 ,2 ,3 ]
机构：
[1] Wenzhou Med Univ, Ctr Sci Res, Affiliated Hosp 2, 109 Xueyuan West Rd, Wenzhou 325027, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Yuying Childrens Hosp, 109 Xueyuan West Rd, Wenzhou 325027, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Dept Pediat, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China
[5] Wenzhou Med Univ, Dept Neurosurg, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China
来源：
STEM CELL RESEARCH | 2021年 / 51卷
关键词：
D O I：
10.1016/j.scr.2021.102159
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
The mutations of polyglutamine binding protein 1 gene (PQBP1) can lead to the rare inherited X-linked Renpenning syndrome (X-RSY). Here, an induced pluripotent stem cell (iPSC) line WMUi017-A was generated through reprogramming the urine cells of a 5-year-old male X-RSY patient with the hemizygous PQBP1 gene mutation p.P609A (c.1825C>G) using the commercial Sendai virus reprogramming system. The established iPSCs can stably express pluripotent stem cell markers OCT4 and NANOG, and can be induced into three germ layers and maintain a normal karyotype (46, XY) in vitro.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Generation of an induced pluripotent stem cell line (ICNDXHi001-A) from a patient with frontotemporal dementia carrying a heterozygous mutation c.796C > G (p.L266V) in MAPT
    Cai, Huimin
    Pang, Yana
    Jia, Longfei
    STEM CELL RESEARCH, 2022, 59
  • [32] An induced pluripotent stem cell line (SHEHi002-A (5426))from a patient of long QT syndrome type 8 with c.2573G>A mutation in the gene CACNA1C
    Zhou, Hong-Mei
    Zhou, Xiao-Qian
    Lu, Ji-Zhen
    Jia, Wen-Wen
    Kang, Jiu-Hong
    STEM CELL RESEARCH, 2020, 43
  • [33] Generation of an integration-free induced pluripotent stem cell line, FJMAi001-A, from a Marfan syndrome patient with a heterozygous mutation c.2777G > A (p.Cys926Tyr) in FBN1
    Liu, Ronghua
    Weng, Guoxing
    Zheng, Fuzhen
    Chen, Jinyan
    Wang, Kun
    Han, Junyong
    Huang, Jie
    Yan, Licheng
    Jin, Jingjun
    STEM CELL RESEARCH, 2024, 81
  • [34] Establishment of a human induced pluripotent stem cell line (CSUASOi005-A), from peripheral blood mononuclear cells of a patient with X-linked juvenile retinoschisis carrying a novel mutation in RS1 gene
    Mao, Shengru
    Ding, Chengcheng
    Zhou, Yalan
    Jing, Yutong
    Chen, Juan
    Guo, Yonglong
    Liu, Jian
    Cui, Zekai
    Yan, Xin
    Gu, Jianing
    Wang, Yini
    Chen, Jiansu
    Tang, Shibo
    STEM CELL RESEARCH, 2020, 43
  • [35] An induced pluripotent stem cell line (TRNDi009-C) from a Niemann-Pick disease type A patient carrying a heterozygous p.L302P (c.905 T > C) mutation in the SMPD1 gene
    Baskfield, Amanda
    Li, Rong
    Beers, Jeanette
    Zou, Jizhong
    Liu, Chengyu
    Zheng, Wei
    STEM CELL RESEARCH, 2019, 38
  • [36] Generation of the induced pluripotent stem cell(iPSC) line (AHQUi001-A) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene
    Sun, Xiaofang
    Zhou, Xiang
    Xiao, Xinhua
    Chi, Jingwei
    Dong, Bingzi
    Wang, Yangang
    STEM CELL RESEARCH, 2020, 45
  • [37] Generating a human induced pluripotent stem cell line (XACHi018-A) from a Timothy syndrome infant carrying heterozygous CACNA1C c.1216G>A > A (p.G406R) mutation
    Jiang, Congshan
    Huang, Wenjun
    Zhou, Yafei
    Wang, Jie
    Lei, Hong
    Niu, Youguo
    Zhou, Rui
    Zhang, Yanmin
    STEM CELL RESEARCH, 2024, 80
  • [38] Generation of an induced pluripotent stem cell line XJHi001-A from a fibronectin glomerulopathy patient carrying a heterozygous NM_212482.2 (C.5888-1G> C) mutation in the FN1 gene
    She, Lecheng
    Li, Xiayin
    Bai, Ming
    STEM CELL RESEARCH, 2023, 72
  • [39] Generation of an induced pluripotent stem cell line (FDCHI007-A) derived from a patient with developmental and epileptic encephalopathy Type 31 carrying heterozygous c.545C > A mutation in DNM1 gene
    Xu, Yan
    Wang, Xinhua
    Qiu, Tian
    Wang, Ji
    Wang, Yi
    Wu, Bingbing
    Zhou, Yuanfeng
    STEM CELL RESEARCH, 2022, 60
  • [40] Generation of an induced pluripotent stem cell (iPSC) line of a Marfan syndrome patient with a pathogenic FBN1 c.5372G > A (p. Cys1791Tyr) variant
    Peeters, Silke
    Fedoryshchenko, Ivanna
    Rabaut, Laura
    Verstraeten, Aline
    Loeys, Bart L.
    STEM CELL RESEARCH, 2023, 68
12345